glp 1 or tirzepatide Explained: The Future of Weight Management Unveiling Tirzepatide's Therapeutic Spectrum: A

Drugs.coms medical review similarly states that there is no clear evidence that Ozempic, Wegovy, Mounjaro or Zepbound directly cause hair loss

This means that you would more than likely get better outcomes than weve seen in the literature

According to the FDA's press release it agreed to approve the drug for obesity based on three randomised, double-blind, placebo-controlled trials during which more than 2,600 patients received Wegovy for up to 68 weeks and more than 1,500 patients received placebo (US FDA 2021)

Pappas in the Journal of Vascular Surgery: Venous and Lymphatic Disorders found that treatment outcomes for chronic venous disease improve as BMI decreases, and that higher BMI is independently associated with poorer results after venous procedures

Grassi G, Mark A, Esler M